Chargement en cours...

Barriers to buprenorphine expansion in Ohio: A time-elapsed qualitative study

Buprenorphine partial opioid agonist pharmacotherapy, a key treatment for opioid use disorders (OUDs), is underutilized in the United States. Qualitative interviews, conducted in 2012/2013 and repeated in 2015, identified systemic barriers to providing buprenorphine treatment in Ohio. A representati...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Psychoactive Drugs
Auteurs principaux: Molfenter, Todd, Fitzgerald, Maureen, Jacobson, Nora, McCarty, Dennis, Quanbeck, Andrew, Zehner, Mark
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6667294/
https://ncbi.nlm.nih.gov/pubmed/30732542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/02791072.2019.1566583
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!